好评率
100%
  • Li F; Mei H; Gao Y, et al., Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer. Biomaterials 2017, 145, 56-71.
    IF: 8.402
    Year: 2017 Journal: Biomaterials
    PubMed: 28843733
  • Wu Q; Tong L; Zou Z, et al., Herceptin-functionalized SK-BR-3 cell membrane-wrapped paclitaxel nanocrystals for enhancing the targeted therapy effect of HER2-positive breast cancer. Materials & Design 2022, 110818.
    IF: 7.991
    Year: 2022 Journal: Mater Design
    DOI:10.1016/j.matdes.2022.110818
  • Du J; Liu X; Sun J, et al., Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer. Breast Cancer Res 2024, 26 (1), 99.
    IF: 7.4
    Year: 2024 Journal: Breast Cancer Res
    PubMed: 38867302
  • Shen W; Ge S; Liu X, et al., Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma. Drug Deliv 2022, 29 (1), 31-42.
    IF: 6.419
    Year: 2021 Journal: Drug Deliv
    PubMed: 34962215
  • Li T Y; Du Y; Wang M C, et al., Cytotoxic Steroidal Saponins Containing a Rare Fructosyl from the Rhizomes of Paris polyphylla var. latifolia. Int J Mol Sci 2023, 24 (8).
    IF: 6.208
    Year: 2023 Journal: Int J Mol Sci
    PubMed: 37108310
  • Zhang F; Cui X; Yang K, et al., Activin A inhibits the migration of human lung adenocarcinoma A549 cells induced by EGF. Int Immunopharmacol 2024, 142 (Pt B), 113170.
    IF: 4.8
    Year: 2024 Journal: Int Immunopharmacol
    PubMed: 39288626
  • Huang M S; Liu J Y; Xia X B, et al., Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway. Front Oncol 2019, 9, 508.
    IF: 4.416
    Year: 2019 Journal: Front Oncol
    PubMed: 31249811
  • Zhu F; Xu L; Li X, et al., Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC. Eur J Pharm Sci 2021, 167, 106004.
    IF: 4.384
    Year: 2021 Journal: Eur J Pharm Sci
    PubMed: 34520834
  • Zheng T; Chou J; Zhang F, et al., CXCR4 3'UTR functions as a ceRNA in promoting metastasis, proliferation and survival of MCF-7 cells by regulating miR-146a activity. Eur J Cell Biol 2015, 94 (10), 458-69.
    IF: 3.699
    Year: 2015 Journal: Eur J Cell Biol
    PubMed: 26095299
  • Wang P; Lan Q; Huang Q, et al., Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation. Biology 2024, 13 (8), 597.
    IF: 3.6
    Year: 2024 Journal: Biology-Basel
    PubMed: 39194535
  • Liu A; Liu Z; Shen H, et al., Potential mechanism prediction of indole-3-propionic acid against diminished ovarian reserve via network pharmacology, molecular docking and experimental verification. BMC Complement Med Ther 2024, 24 (1), 316.
    IF: 3.3
    Year: 2024 Journal: BMC Complement Med
    PubMed: 39192219
  • Zhang C; Liu Y; Yang F, et al., MicroRNA-194-5p/Heparin-binding EGF-like growth factor signaling mediates dexamethasone-induced activation of pseudorabies virus in rat pheochromocytoma cells. Vet Microbiol 2024, 290, 109974.
    IF: 3.3
    Year: 2024 Journal: Vet Microbiol
    PubMed: 38262115
  • Pan Z; Wang K; Chen Q, et al., SFI Enhances Therapeutic Efficiency of Gefitinib: An Insight into Reversal of Resistance to Targeted Therapy in Non-small Cell Lung Cancer Cells. J Cancer 2020, 11 (2), 334-344.
    IF: 3.182
    Year: 2020 Journal: J Cancer
    PubMed: 31897229
0
产品咨询微信

服务热线

400-602-0407

APP下载
生物狗小程序